A detailed history of D. E. Shaw & Co., Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,349 shares of TECH stock, worth $254,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,349
Holding current value
$254,390
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $208,039 - $281,818
3,349 New
3,349 $239,000
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $1.28 Million - $1.69 Million
18,886 Added 23.72%
98,496 $6.7 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $18.4 Million - $21.5 Million
-249,564 Reduced 75.82%
79,610 $6.5 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $22.1 Million - $26.7 Million
308,681 Added 1506.28%
329,174 $24.4 Million
Q4 2022

Feb 14, 2023

SELL
$80.67 - $352.29 $1.06 Million - $4.62 Million
-13,128 Reduced 39.05%
20,493 $1.7 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $391,600 - $543,104
-1,386 Reduced 3.96%
33,621 $9.55 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $6.36 Million - $8.86 Million
19,709 Added 128.83%
35,007 $12.1 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $1.58 Million - $2.18 Million
4,470 Added 41.28%
15,298 $6.62 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $879,457 - $1.01 Million
1,928 Added 21.66%
10,828 $5.6 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $1.07 Million - $1.3 Million
2,411 Added 37.16%
8,900 $4.31 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $1.25 Million - $1.46 Million
-3,238 Reduced 33.29%
6,489 $2.92 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $359,925 - $470,184
-1,144 Reduced 10.52%
9,727 $3.72 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $1.79 Million - $2.34 Million
-7,261 Reduced 40.05%
10,871 $3.45 Million
Q3 2020

Nov 16, 2020

BUY
$232.22 - $282.96 $892,653 - $1.09 Million
3,844 Added 26.9%
18,132 $4.49 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $8.78 Million - $13.2 Million
-47,354 Reduced 76.82%
14,288 $3.77 Million
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $2.39 Million - $3.28 Million
-14,802 Reduced 19.36%
61,642 $11.7 Million
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $306,333 - $358,675
1,615 Added 2.16%
76,444 $16.8 Million
Q3 2019

Nov 14, 2019

BUY
$183.56 - $216.72 $3.91 Million - $4.61 Million
21,278 Added 39.73%
74,829 $14.6 Million
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $1.8 Million - $2.06 Million
9,563 Added 21.74%
53,551 $11.2 Million
Q1 2019

May 15, 2019

SELL
$136.09 - $200.44 $4.57 Million - $6.73 Million
-33,559 Reduced 43.28%
43,988 $8.73 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $8.23 Million - $12.6 Million
62,029 Added 399.72%
77,547 $11.2 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $2.71 Million - $3.75 Million
-18,370 Reduced 54.21%
15,518 $3.17 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $479,184 - $547,573
3,307 Added 10.81%
33,888 $5.01 Million
Q1 2018

May 15, 2018

SELL
$131.46 - $151.04 $1.56 Million - $1.79 Million
-11,840 Reduced 27.91%
30,581 $4.62 Million
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $1.42 Million - $1.58 Million
11,737 Added 38.25%
42,421 $5.5 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $3.49 Million - $3.8 Million
30,684
30,684 $3.71 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.98B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.